NEUROCRINE BIOSCIENCES INC (NBIX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch NBIX
See up to 3 months of NBIX. The 7-day demo opens the 1M and 3M ranges and puts NBIX on your watchlist.
Start 7-day demoLatest NBIX insider trades
About NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC is an SEC registrant, filing under CIK 0000914475, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
NBIX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 6,541 | $1.05M |
| Grant or award | 11 | 57,396 | |
| Option exercise | 4 | 8,072 | |
NBIX insider transactions (Form 4)
91101 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Jude Onyia - Officer | Grant or award | Common Stock | 3,587 | $0.00 | - | |
| Jude Onyia - Officer | Tax withholding / forfeiture | Common Stock | 1,936 | $156.22 | $302K | |
| Darin Lippoldt - Officer | Grant or award | Common Stock | 4,483 | $0.00 | - | |
| Darin Lippoldt - Officer | Tax withholding / forfeiture | Common Stock | 2,419 | $156.22 | $378K | |
| Sanjay Chandru Keswani - Officer | Grant or award | Common Stock | 3,914 | $0.00 | - | |
| Sanjay Chandru Keswani - Officer | Tax withholding / forfeiture | Common Stock | 2,112 | $156.22 | $330K | |
 Kevin Charles Gorman - Director | Grant or award | Common Stock | 14,343 | $0.00 | - | |
| Kevin Charles Gorman - Director | Tax withholding / forfeiture | Common Stock | 7,839 | $156.22 | $1.22M | |
| Kyle Gano - Officer | Grant or award | Common Stock | 6,275 | $0.00 | - | |
| Kyle Gano - Officer | Tax withholding / forfeiture | Common Stock | 3,386 | $156.22 | $529K | |
| Kyle Gano - Officer | Grant or award | Common Stock | 1,842 | $0.00 | - | |
| Kyle Gano - Officer | Tax withholding / forfeiture | Common Stock | 994 | $156.22 | $155K | |
| Ingrid Delaet - Officer | Grant or award | Common Stock | 4,483 | $0.00 | - | |
| Ingrid Delaet - Officer | Tax withholding / forfeiture | Common Stock | 2,419 | $156.22 | $378K | |
 Julie Cooke - Officer | Grant or award | Common Stock | 3,587 | $0.00 | - | |
| Julie Cooke - Officer | Tax withholding / forfeiture | Common Stock | 1,936 | $156.22 | $302K | |
| David W. Boyer - Officer | Grant or award | Common Stock | 3,587 | $0.00 | - | |
| David W. Boyer - Officer | Tax withholding / forfeiture | Common Stock | 1,936 | $156.22 | $302K | |
| David W. Boyer - Officer | Open-market sale | Common Stock | 826 | $157.45 footnote F5 | $130K | |
| ||||||
| Eric Benevich - Officer | Grant or award | Common Stock | 6,275 | $0.00 | - | |
| Eric Benevich - Officer | Tax withholding / forfeiture | Common Stock | 3,386 | $156.22 | $529K | |
| Matt Abernethy - Officer | Grant or award | Common Stock | 5,020 | $0.00 | - | |
| Matt Abernethy - Officer | Tax withholding / forfeiture | Common Stock | 2,709 | $156.22 | $423K | |
| Matt Abernethy - Officer | Open-market sale | Common Stock | 2,311 | $157.20 footnote F4 | $363K | |
| ||||||
| Eric Benevich - Officer | Option exercise | Common Stock | 3,194 | $43.24 | $138K | |
| Eric Benevich - Officer | Open-market sale | Common Stock | 2,154 | $154.61 | $333K | |
| Eric Benevich - Officer | Option exercise | Incentive Stock Option | 3,194 | $0.00 | - | |
| Stephen A. Sherwin - Director | Gift | Common Stock | 1,000 | $0.00 | - | |
| Jude Onyia - Officer | Gift | Common Stock | 2,409 | $0.00 | - | |
| Leslie V. Norwalk - Director | Option exercise | Common Stock | 842 | $139.43 | $117K | |
| Leslie V. Norwalk - Director | Open-market sale | Common Stock | 1,250 | $182.01 footnote F2 | $228K | |
| Leslie V. Norwalk - Director | Option exercise | Non-Qualified Stock Option | 842 | $0.00 | - | |
| ||||||
| Ingrid Delaet - Officer | Option exercise | Common Stock | 4,367 | $106.02 | $463K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 4,367 | $181.02 | $791K | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 4,367 | $0.00 | - | |
| Darin Lippoldt - Officer | Option exercise | Common Stock | 10,000 | $81.49 | $815K | |
| Darin Lippoldt - Officer | Open-market sale | Common Stock | 10,000 | $179.60 footnote F2 | $1.80M | |
| Darin Lippoldt - Officer | Option exercise | Non-Qualified Stock Option | 10,000 | $0.00 | - | |
| ||||||
| Ingrid Delaet - Officer | Option exercise | Common Stock | 3,401 | $103.52 | $352K | |
| Ingrid Delaet - Officer | Option exercise | Common Stock | 2,737 | $103.52 | $283K | |
| Ingrid Delaet - Officer | Option exercise | Common Stock | 8,433 | $103.52 | $873K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 3,401 | $178.57 footnote F2 | $607K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 2,737 | $178.54 footnote F3 | $489K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 8,433 | $178.72 footnote F4 | $1.51M | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 3,401 | $0.00 | - | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 2,737 | $0.00 | - | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 8,433 | $0.00 | - | |
| ||||||
| Darin Lippoldt - Officer | Option exercise | Common Stock | 200 | $81.49 | $16K | |
| Darin Lippoldt - Officer | Option exercise | Common Stock | 8,110 | $81.49 | $661K | |
| Darin Lippoldt - Officer | Option exercise | Common Stock | 1,690 | $81.49 | $138K | |
| Darin Lippoldt - Officer | Open-market sale | Common Stock | 200 | $169.57 footnote F2 | $34K | |
| Darin Lippoldt - Officer | Open-market sale | Common Stock | 8,110 | $170.03 footnote F3 | $1.38M | |
| Darin Lippoldt - Officer | Open-market sale | Common Stock | 1,690 | $170.81 footnote F4 | $289K | |
| Darin Lippoldt - Officer | Option exercise | Non-Qualified Stock Option | 200 | $0.00 | - | |
| Darin Lippoldt - Officer | Option exercise | Non-Qualified Stock Option | 8,110 | $0.00 | - | |
| Darin Lippoldt - Officer | Option exercise | Non-Qualified Stock Option | 1,690 | $0.00 | - | |
| ||||||
| Stephen A. Sherwin - Director | Open-market sale | Common Stock | 6,896 | $165.79 footnote F4 | $1.14M | |
| Stephen A. Sherwin - Director | Open-market sale | Common Stock | 5,829 | $166.56 footnote F5 | $971K | |
| Stephen A. Sherwin - Director | Open-market sale | Common Stock | 1,843 | $167.31 footnote F6 | $308K | |
| Stephen A. Sherwin - Director | Option exercise | Non-Qualified Stock Option | 15,000 | $0.00 | - | |
| Stephen A. Sherwin - Director | Option exercise | Non-Qualified Stock Option | 10,000 | $0.00 | - | |
| Stephen A. Sherwin - Director | Open-market sale | Common Stock | 7,883 | $163.81 footnote F2 | $1.29M | |
| Stephen A. Sherwin - Director | Option exercise | Common Stock | 15,000 | $53.64 | $805K | |
| Stephen A. Sherwin - Director | Option exercise | Common Stock | 10,000 | $79.79 | $798K | |
| Stephen A. Sherwin - Director | Open-market sale | Common Stock | 2,549 | $164.44 footnote F3 | $419K | |
| ||||||
| Jude Onyia - Officer | Gift | Common Stock | 2,441 | $0.00 | - | |
| Leslie V. Norwalk - Director | Open-market sale | Common Stock | 1,250 | $168.06 footnote F2 | $210K | |
| ||||||
| Julie Cooke - Officer | Option exercise | Common Stock | 24,965 | $81.49 | $2.03M | |
| Julie Cooke - Officer | Open-market sale | Common Stock | 14,214 | $154.83 footnote F3 | $2.20M | |
| Julie Cooke - Officer | Open-market sale | Common Stock | 5,466 | $155.46 footnote F4 | $850K | |
| Julie Cooke - Officer | Open-market sale | Common Stock | 4,216 | $156.77 footnote F5 | $661K | |
| Julie Cooke - Officer | Open-market sale | Common Stock | 9,521 | $157.62 footnote F6 | $1.50M | |
| Julie Cooke - Officer | Open-market sale | Common Stock | 3,520 | $158.59 footnote F7 | $558K | |
| Julie Cooke - Officer | Option exercise | Non-Qualified Stock Option | 24,965 | $0.00 | - | |
| ||||||
| Sanjay Chandru Keswani - Officer | Option exercise | Common Stock | 3,212 | $0.00 | - | |
| Sanjay Chandru Keswani - Officer | Tax withholding / forfeiture | Common Stock | 1,733 footnote F1 | $154.84 | $268K | |
| Sanjay Chandru Keswani - Officer | Option exercise | Restricted Stock Unit | 3,212 | $0.00 | - | |
| ||||||
| Jude Onyia - Officer | Option exercise | Common Stock | 11,000 | $84.74 | $932K | |
| Jude Onyia - Officer | Open-market sale | Common Stock | 11,000 | $160.25 footnote F2 | $1.76M | |
| Jude Onyia - Officer | Option exercise | Non-Qualified Stock Option | 11,000 | $0.00 | - | |
| ||||||
| Ingrid Delaet - Officer | Option exercise | Common Stock | 2,261 | $79.02 | $179K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 2,261 | $156.71 | $354K | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 2,261 | $0.00 | - | |
| Jude Onyia - Officer | Option exercise | Common Stock | 11,000 | $84.74 | $932K | |
| Jude Onyia - Officer | Open-market sale | Common Stock | 11,000 | $155.53 footnote F3 | $1.71M | |
| Jude Onyia - Officer | Option exercise | Non-Qualified Stock Option | 11,000 | $0.00 | - | |
| ||||||
| Kevin Charles Gorman - Director | Grant or award | Non-Qualified Stock Option | 5,248 | $0.00 | - | |
| Richard F. Pops - Director | Grant or award | Restriced Stock Unit | 2,567 | $0.00 | - | |
| Gary A. Lyons - Director | Grant or award | Restriced Stock Unit | 1,284 | $0.00 | - | |
| Gary A. Lyons - Director | Grant or award | Non-Qualified Stock Option | 2,624 | $0.00 | - | |
| Johanna Mercier - Director | Grant or award | Restriced Stock Unit | 2,567 | $0.00 | - | |
Item 5.02
Item 9.01
Item 2.02, 9.01
Item 5.02, 5.07
Recent NBIX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| DAVID WARREN BOYER | Officer | 4,714 | $736K | View on EDGAR | |
| MATTHEW C ABERNETHY | Officer | 2,311 | $361K |
NBIX insider trading FAQ
What is the latest insider trade for NBIX?
NEUROCRINE BIOSCIENCES INC (NBIX) had 14 insider filings in the last 90 days, with the most recent on 2026-09-15. The full record for NBIX runs to 101 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NBIX stock?
No insider purchases of NBIX were filed in the last 90 days.
How many insiders are selling NBIX stock?
4 insider sales of NBIX were filed in the last 90 days, totaling $1.05M.
Where can I see NBIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NBIX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jude Onyia view on EDGAR
- - Darin Lippoldt view on EDGAR
- - Sanjay Chandru Keswani view on EDGAR
- - Kevin Charles Gorman view on EDGAR
- - Kyle Gano view on EDGAR
- - Ingrid Delaet view on EDGAR
- - Julie Cooke view on EDGAR
- - David W. Boyer view on EDGAR
- - Eric Benevich view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NBIX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NBIX with a 7-day demo
- NBIX on your watchlist
- Every NBIX Form 4 filing on record
- Up to 3 months of NBIX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
